Analgesic Solutions Presents Data On The Use Of MADDERS To Assess Potentially Abuse-Related Events In Clinical Trials At The Post author:Sam Post published:June 18, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Johnson & Johnson's Imbruvica Scores Expanded FDA Approval for Chronic Graft vs Host Disease August 2, 2017 The European Commission (EC) Finally Approves Merck KGaA's Once-Failed MS Drug Cladribine August 24, 2017 Acorda Plunges After the FDA Rejects Marketing App for Parkinson's Disease Drug August 28, 2017
Johnson & Johnson's Imbruvica Scores Expanded FDA Approval for Chronic Graft vs Host Disease August 2, 2017
The European Commission (EC) Finally Approves Merck KGaA's Once-Failed MS Drug Cladribine August 24, 2017